OBJECTIVE: Diffusion tensor imaging (DTI) quantifies Brownian motion of water within tissue. The goal of this study was to test whether, following a remote episode of optic neuritis (ON), breakdown of myelin and axons within the optic nerve could be detected by alterations in DTI parameters, and whether these alterations would correlate with visual loss. METHODS: Seventy subjects with a history of ON > or =6 months prior underwent DTI of the optic nerves, assessment of visual acuities (VA) and contrast sensitivities (CS), and laboratory measures of visual evoked potentials (VEP) and optical coherence tomography (OCT). RESULTS: Radial diffusivity (RD) correlated with visual acuity (r = -0.61), Pelli-Robson CS (r = -0.60), 5%CS (r = 0.61), OCT (r = -0.78), VEP latency (r = 0.61), and VEP amplitude (r = -0.46). RD differentiated the unaffected fellow nerves from affected nerves in all visual outcome categories. RD also discriminated nerves with recovery to normal from mild visual impairment, and those with mild impairment from profound visual loss. RD differentiated healthy controls from both clinically affected nerves and unaffected fellow nerves after ON. RD differentiated all categories of 5%CS outcomes, and all categories of Pelli-Robson CS with the exception of normal recovery from mildly affected. CONCLUSIONS: Increased optic nerve radial diffusivity (RD) detected by diffusion tensor imaging (DTI) was associated with a proportional decline in vision after optic neuritis. RD can differentiate healthy control nerves from both affected and unaffected fellow nerves. RD can discriminate among categories of visual recovery within affected eyes. Optic nerve injury as assessed by DTI was corroborated by both optical coherence tomography and visual evoked potentials.
OBJECTIVE: Diffusion tensor imaging (DTI) quantifies Brownian motion of water within tissue. The goal of this study was to test whether, following a remote episode of optic neuritis (ON), breakdown of myelin and axons within the optic nerve could be detected by alterations in DTI parameters, and whether these alterations would correlate with visual loss. METHODS: Seventy subjects with a history of ON > or =6 months prior underwent DTI of the optic nerves, assessment of visual acuities (VA) and contrast sensitivities (CS), and laboratory measures of visual evoked potentials (VEP) and optical coherence tomography (OCT). RESULTS: Radial diffusivity (RD) correlated with visual acuity (r = -0.61), Pelli-Robson CS (r = -0.60), 5%CS (r = 0.61), OCT (r = -0.78), VEP latency (r = 0.61), and VEP amplitude (r = -0.46). RD differentiated the unaffected fellow nerves from affected nerves in all visual outcome categories. RD also discriminated nerves with recovery to normal from mild visual impairment, and those with mild impairment from profound visual loss. RD differentiated healthy controls from both clinically affected nerves and unaffected fellow nerves after ON. RD differentiated all categories of 5%CS outcomes, and all categories of Pelli-Robson CS with the exception of normal recovery from mildly affected. CONCLUSIONS: Increased optic nerve radial diffusivity (RD) detected by diffusion tensor imaging (DTI) was associated with a proportional decline in vision after optic neuritis. RD can differentiate healthy control nerves from both affected and unaffected fellow nerves. RD can discriminate among categories of visual recovery within affected eyes. Optic nerve injury as assessed by DTI was corroborated by both optical coherence tomography and visual evoked potentials.
Authors: J S Shimony; R C McKinstry; E Akbudak; J A Aronovitz; A Z Snyder; N F Lori; T S Cull; T E Conturo Journal: Radiology Date: 1999-09 Impact factor: 11.105
Authors: Frederik Barkhof; Wolfgang Bruck; Corline J A De Groot; Elisabeth Bergers; Sandra Hulshof; Jeroen Geurts; Chris H Polman; Paul van der Valk Journal: Arch Neurol Date: 2003-08
Authors: Simon J Hickman; Claudia A M Wheeler-Kingshott; Stephen J Jones; Katherine A Miszkiel; Gareth J Barker; Gordon T Plant; David H Miller Journal: AJNR Am J Neuroradiol Date: 2005-04 Impact factor: 3.825
Authors: Claudia A M Wheeler-Kingshott; Geoffrey J M Parker; Mark R Symms; Simon J Hickman; Paul S Tofts; David H Miller; Gareth J Barker Journal: Magn Reson Med Date: 2002-01 Impact factor: 4.668
Authors: Yong Wang; Peng Sun; Qing Wang; Kathryn Trinkaus; Robert E Schmidt; Robert T Naismith; Anne H Cross; Sheng-Kwei Song Journal: Brain Date: 2015-02-26 Impact factor: 13.501
Authors: Tsen-Hsuan Lin; William M Spees; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song Journal: Neurobiol Dis Date: 2014-03-13 Impact factor: 5.996
Authors: Eric C Klawiter; Robert E Schmidt; Kathryn Trinkaus; Hsiao-Fang Liang; Matthew D Budde; Robert T Naismith; Sheng-Kwei Song; Anne H Cross; Tammie L Benzinger Journal: Neuroimage Date: 2011-01-13 Impact factor: 6.556
Authors: Jiwon Oh; Shiv Saidha; Min Chen; Seth A Smith; Jerry Prince; Craig Jones; Marie Diener-West; Peter C M van Zijl; Daniel S Reich; Peter A Calabresi Journal: Neurology Date: 2013-01-16 Impact factor: 9.910
Authors: Shiv Saidha; Elias S Sotirchos; Jiwon Oh; Stephanie B Syc; Michaela A Seigo; Navid Shiee; Chistopher Eckstein; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Teresa C Frohman; Scott Newsome; John N Ratchford; Laura J Balcer; Dzung L Pham; Ciprian M Crainiceanu; Elliot M Frohman; Daniel S Reich; Peter A Calabresi Journal: JAMA Neurol Date: 2013-01 Impact factor: 18.302